| |

Personalized Exercise Program Improves Mesothelioma Quality of Life

exercise programA new case study suggests that a personalized exercise program could improve the quality of life for people fighting malignant mesothelioma.

An estimated 2,500 Americans receive a mesothelioma diagnosis every year. Most of them are over 65. This population is typically less active than younger people anyway. It can be even harder to get enough physical activity when they are depleted by cancer and treatment.

Research shows that physical activity does more than make patients stronger. It can also help them fight cancers like malignant mesothelioma. But many patients still do not get enough.

The new report shows how a custom exercise program can help mesothelioma patients feel and function better.

Physical Activity and Mesothelioma Treatment

Pleural mesothelioma is a lung-related cancer caused by asbestos. People with pleural mesothelioma may be short of breath, anxious, and fatigued. They may also feel weak or have digestive problems. Treatments like chemotherapy and radiation often make these symptoms even worse.

The American Lung Association says an exercise program can help. Physical activity boosts energy, lowers stress, improves self-esteem, stimulates appetite, and makes muscles stronger. It may also help with breathing and digestive problems. 

The American Cancer Society says exercise can reduce treatment-associated nausea and prevent isolation.

An exercise program is so essential to cancer care that the Clinical Oncology Society of Australia (COSA) recommends it for all patients. COSA released a statement to that effect in 2018. It says exercise is “a safe and effective intervention to counteract the adverse physical and psychological effects of cancer and its treatment.”

COSA says mesothelioma patients should aim for at least 2.5 hours of moderate aerobic exercise every week. They should also have 2 to 3 moderate intensity resistance exercise sessions.

How a Personalized Exercise Program Can Help

The author of the new report says group programs for cancer patients are “often lacking appropriate intensity and volume.” As a result, patients make little improvement or even go backward in their physical well-being.

Andrew Chongaway, a Physical Therapist at Beaumont Health in Michigan, authored the new case study. It details the experience of a hospitalized mesothelioma patient. The patient had an individualized exercise program. It included isometric strength training (ISO) and high-intensity interval training (HIIT).

“The patient demonstrated improvement in functional mobility evidenced by improvement in Activity Measure for Post-Acute Care (AM-PAC) score through the hospitalization along with increased ambulation distance,” writes Chongaway.

The patient did not have any problems as a result of their increased physical activity.

The case for exercise is overwhelmingly positive. But mesothelioma patients should still talk with their oncologist before beginning an exercise program. Many hospitals now offer fitness classes for cancer patients and survivors.

Sources:

Chongaway, A, et al, “Utilization of Isometric Strength Training and Interval Training With a Patient With Cancer in the Acute Care Setting”, June 10, 2021, Cureus, eCollection, https://www.cureus.com/articles/55307-utilization-of-isometric-strength-training-and-interval-training-with-a-patient-with-cancer-in-the-acute-care-setting

Similar Posts

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • |

    Chemical in Wine May Improve Mesothelioma Treatment

    There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…

  • | |

    Micro-RNAs May Offer New Way to Fight Mesothelioma

    Scientists at one of the world’s top mesothelioma research centers, the Asbestos Diseases Research institute in Sydney, Australia, say that restoring the expression of certain micro RNAs in the cells of mesothelioma patients may offer a new way to fight the disease. A microRNA is a small RNA molecule which is involved in the regulation of gene expression. According to a new report in the Annals of Oncology, the Australian scientists found reduced expression of the micro RNA-15 family (miR-15/16) in the cells of mice with mesothelioma. “When malignant pleural mesothelioma cell lines were compared with the normal mesothelial cell line MeT-5A, the downregulation of miR-15/16 was 2- to 10-fold,” they report. This finding is consistent with previous cancer research…

  • | |

    Treatment Uses Herpes Virus to Shrink Mesothelioma Tumors

    Researchers at a hospital in Sheffield, England are testing a potential new mesothelioma treatment based on the same virus that causes herpes. The small-scale trial is the first in the world to test the modified herpes simplex virus, HSV1716, in human mesothelioma patients. HSV1716 has been genetically engineered to infect and kill cancer cells without harming healthy cells. In laboratory studies on mesothelioma and some other cancers, it has been shown to be effective at shrinking tumors while causing limited toxicity. Just as significantly, HSV1716 increased survival rates among mice with various human cancers. The Phase I/II trial at Sheffield Experimental Cancer Medicine Centre is the next stage in development of HSV1716 as a viable mesothelioma treatment. The goal of…

  • | |

    New Mesothelioma Drug Kills Cancer Stem Cells

    Citing “significant enthusiasm within the mesothelioma community”, the manufacturers of a promising new mesothelioma drug say they have begun a major test of the drug in patients. Massachusetts-based Verastem, Inc. focuses on drugs that fight cancer by attacking the stem cells that give rise to them. Earlier this summer, the FDA granted orphan drug status to their stem cell inhibitor, defactinib, for the treatment of mesothelioma. The designation, which is reserved for drugs that fight the rarest of diseases, helps pave the way for testing and faster approval, depending on the results of clinical trials. “Development of a drug that preferentially kills cancer stem cells is a promising approach, as many standard-of-care treatments have been shown to either have no…

  • | |

    Mesothelioma Study Finds New Treatment Target

    Immunotherapy, which involves reprogramming T-cells to find and attack cancer cells, is one of the fastest-growing areas of cancer research. One of the biggest challenges of immunotherapy is how to harness the power of T-cells against cancer without also turning them against healthy cells. A new study conducted in Switzerland and published in the Journal of Translational Medicine addressed the problem by reprogramming T-cells to recognize and attack mesothelioma cells that express a specific protein. Fibroblast Activation Protein (FAP) is expressed on the surface of tumor-associated fibroblast cells which are found in the connective tissue of mesothelioma tumors. FAP is also found in mesothelioma cells and may play a role in the start of cancer, as well as the growth…